Pharmacy Usual Items - Central Asia

  • Central Asia
  • Revenue in the Pharmacy Usual Items market is projected to reach US$1.87bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.43%, resulting in a market volume of US$1.83bn by 2029.
  • In global comparison, most revenue will be generated in China (US$48,050.00m in 2024).
  • In relation to total population figures, per person revenues of US$23.53 are generated in 2024.

Key regions: Japan, France, China, Australia, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacy Usual Items market in Central Asia is experiencing significant growth and development due to several factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the expansion of this market. Customer preferences in Central Asia are shifting towards a greater focus on healthcare and personal well-being. As the region continues to develop and the middle class expands, consumers are becoming more health-conscious and are willing to spend more on pharmaceutical products. This increased demand for pharmacy usual items is driving the growth of the market. Trends in the market also play a crucial role in its development. Central Asia is witnessing a rise in chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders. This has created a higher demand for medications and other pharmacy usual items to manage these conditions. Additionally, there is a growing trend of self-medication among consumers, leading to increased sales of over-the-counter drugs and other pharmacy usual items. Local special circumstances in Central Asia further contribute to the growth of the Pharmacy Usual Items market. The region has a relatively young population, with a large proportion of people under the age of 30. This demographic trend, coupled with increasing urbanization, is driving the demand for healthcare products and services. Moreover, the government in Central Asia is investing heavily in healthcare infrastructure and promoting the development of the pharmaceutical industry, which creates a favorable environment for the growth of the Pharmacy Usual Items market. Underlying macroeconomic factors also play a significant role in the development of the Pharmacy Usual Items market in Central Asia. The region is experiencing steady economic growth, which has resulted in increased disposable income and improved living standards. As a result, consumers are willing to spend more on healthcare products, including pharmacy usual items. Furthermore, Central Asia is witnessing a rise in medical tourism, with patients from neighboring countries seeking affordable healthcare services in the region. This has further boosted the demand for pharmacy usual items. In conclusion, the Pharmacy Usual Items market in Central Asia is experiencing growth and development due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As the region continues to develop and the demand for healthcare products increases, the market is expected to expand further in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)